Anti-EGFR x Anti-HER3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-EGFR and anti-HER3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Solid tumors therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY